Understand what your environmental toxins results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
MEOHP and why it reflects DEHP exposure
MEOHP is a urinary metabolite of DEHP, a high-volume plasticizer used to make polyvinyl chloride (PVC) flexible. Think vinyl flooring, wire insulation, certain food-contact materials, and some medical tubing. DEHP isn’t chemically bound to plastic, so small amounts can migrate into air, dust, and food. People typically encounter it by ingesting food that contacted DEHP-containing materials, breathing indoor air or dust, or through medical devices during procedures. Labs measure MEOHP in urine using mass spectrometry; because DEHP clears relatively quickly, a single urine measurement reflects recent exposure over the past day or two rather than a long-term body burden.
Why it matters: DEHP and its metabolites interact with hormonal pathways (notably anti-androgenic effects), activate receptors that regulate metabolism (like PPARs), and can increase oxidative stress. After exposure, DEHP is absorbed, rapidly transformed in the liver into metabolites such as MEOHP, and excreted by the kidneys. DEHP does not persist for years the way PFAS do, but repeated low-level contact can keep levels detectable. Large biomonitoring studies consistently find phthalate metabolites like MEOHP in a majority of people, a signal that everyday environments can contribute to ongoing exposure, though individual health risk depends on dose, timing, and personal susceptibility.
Why MEOHP is worth measuring
MEOHP testing connects a real-world question—did something in my routine recently raise my exposure?—to how DEHP-related metabolites behave in the body. Because this metabolite reflects short-term exposure, a result can help differentiate incidental contact (for example, a takeout meal packaged in soft plastic) from a pattern that suggests repeated sources, like particular workplace materials or frequent use of DEHP-containing products. That distinction matters for understanding symptom clusters that sometimes correlate with phthalate exposure, such as shifts in reproductive hormones, subtle thyroid effects, or signs of oxidative stress. It is also relevant for people with intensive medical device contact, including dialysis or certain infusion therapies. Pregnancy and early childhood are periods of special interest, given evidence that anti-androgenic phthalates may influence fetal and child development, though human studies are largely observational and dose dependent.
At the big-picture level, an MEOHP result is most useful alongside other environmental biomarkers, general health labs, and your lived context. A single value offers a snapshot; repeated measurements, paired with notes about food packaging, home renovations, or occupational tasks, reveal whether you are seeing transient spikes or a steady signal. Over time, that pattern helps you and your clinician judge relevance, weigh trade-offs, and prioritize realistic, evidence-aligned changes. This is the same logic many people use with wearable recovery data: one off-night doesn’t define fitness, but consistent trends do. For environmental exposures, trends and context—not isolated numbers—are what ultimately guide safer choices.
Who tends to benefit from an MEOHP test
People curious about everyday exposure who want a concrete, lab-based readout often find it useful. It can be especially informative for those in high-contact settings (e.g., PVC manufacturing, recycling, healthcare with frequent device exposure), for families planning pregnancy, or for individuals experiencing hormone-related concerns where environmental contributors are being considered. Children and pregnant individuals are life stages where lower exposure is generally preferred, recognizing that interpretation should be cautious and guided by a clinician. For anyone, repeating the test after a meaningful change—like updating food-storage habits or completing a medical treatment cycle—helps confirm whether levels shift in the expected direction.
Reading an MEOHP result
Most labs report MEOHP against population-based reference ranges, sometimes including percentiles from national surveys. With environmental toxins, lower values are generally preferable when achievable, and because hydration can dilute or concentrate urine, results may be “creatinine-corrected” to standardize interpretation. Since MEOHP reflects the prior 24–48 hours, repeat testing and notes on recent exposures improve clarity.
Relatively lower values usually signal limited recent contact with DEHP-containing materials and a lower likelihood of short-term stress on hormone signaling or detox pathways. In pregnancy planning or early childhood contexts, lower results are reassuring in that moment in time, while still benefiting from periodic rechecks if circumstances change.
Relatively higher values can indicate recent or ongoing sources—for example, certain flexible PVC materials in the home, workplace, or medical settings—and may correspond with added workload for the liver and kidneys as they process and excrete metabolites. Depending on susceptibility and timing, endocrine-related effects are the most discussed with DEHP-class phthalates; some studies also link higher metabolite levels with markers of oxidative stress. Because spot urine can vary with hydration and daily routines, it is wise to confirm elevations with trends and context, rather than drawing conclusions from a single result.
Bottom line: MEOHP is most meaningful when viewed next to other phthalate metabolites, related health markers, and your day-to-day reality. That integrated view helps distinguish a one-time spike from a persistent exposure pattern and supports informed, practical decisions with your clinician’s guidance.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
What can move an MEOHP reading
Think of MEOHP as a quick status check after a normal week. If you just renovated a room with new vinyl flooring, ate several meals packaged in soft plastic, or spent long hours in a workshop with flexible PVC, a test can capture the short-term impact. If nothing stands out but results are persistently higher on repeat testing, that’s a clue to look for subtle contributors like specific food-contact items, indoor dust reservoirs, or recurring medical device contact. For many, simple pattern recognition—what happened in the 48 hours before each test—reveals the “aha” moments.
This is a urine test performed by advanced mass spectrometry. Results may be reported as a raw concentration and/or creatinine-normalized value to account for hydration. Because half-life is short, timing matters: results reflect recent exposure and can vary day to day. Inter-lab methods and reference ranges differ, so comparing results to the same lab over time is best. MEOHP is one of several DEHP metabolites; clinicians often consider it alongside related markers to strengthen interpretation. Associations between higher phthalate metabolites and health outcomes come from a mix of animal experiments and human observational studies; they point to plausible risks, but individual results require context and clinical judgment.
Frequently Asked Questions
References
- Koch HM, Preuss R, Angerer J (2006). Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure--an update and latest results. *International Journal of Andrology*, *29*(1), 155-165. https://doi.org/10.1111/j.1365-2605.2005.00607.x
- Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, Needham LL, Calafat AM (2004). Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. *Environmental Health Perspectives*, *112*(3), 331-338. https://doi.org/10.1289/ehp.6723
- Rowdhwal SSS, Chen J (2018). Toxic effects of di-2-ethylhexyl phthalate: an overview. *BioMed Research International*, *2018*, 1750368. https://doi.org/10.1155/2018/1750368
- Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC (2009). Endocrine-disrupting chemicals: an Endocrine Society scientific statement. *Endocrine Reviews*, *30*(4), 293-342. https://doi.org/10.1210/er.2009-0002
- Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL (2005). Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. *Environmental Health Perspectives*, *113*(2), 192-200. https://doi.org/10.1289/ehp.7337
